Emergent BioSolutions (EBS) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.62 +2.90%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.75, $0.13 better than the analyst estimate of $0.62. Revenue for the quarter came in at $270.7 million versus the consensus estimate of $270.03 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
